Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer.
Shigematsu H, Kadoya T, Kobayashi Y, Kajitani K, Sasada T, Emi A, Masumoto N, Haruta R, Kataoka T, Oda M, Arihiro K, Okada M. Shigematsu H, et al. Among authors: kadoya t. World J Surg Oncol. 2011 Nov 7;9:146. doi: 10.1186/1477-7819-9-146. World J Surg Oncol. 2011. PMID: 22059982 Free PMC article.
The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial.
Shigematsu H, Kadoya T, Masumoto N, Sasada T, Emi A, Ohara M, Kajitani K, Okada M. Shigematsu H, et al. Among authors: kadoya t. Clin Breast Cancer. 2015 Apr;15(2):110-6. doi: 10.1016/j.clbc.2014.09.010. Epub 2014 Oct 2. Clin Breast Cancer. 2015. PMID: 25454688 Clinical Trial.
259 results